|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8719963D0
(en)
|
1987-08-24 |
1987-09-30 |
Cattaneo A |
Recombinant dna products
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2050918A1
(en)
|
1990-01-12 |
1991-07-13 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
|
US6476198B1
(en)
|
1993-07-13 |
2002-11-05 |
The Scripps Research Institute |
Multispecific and multivalent antigen-binding polypeptide molecules
|
|
UA40577C2
(uk)
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
|
AU697387C
(en)
|
1994-09-16 |
2006-03-02 |
Austin Research Institute Cancer and Anti-inflammatory Syndicate No 1 |
Polypeptides with Fc binding ability
|
|
US6808709B1
(en)
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
|
US6165463A
(en)
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US8212004B2
(en)
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
CA2276046A1
(en)
*
|
1997-01-10 |
1998-07-16 |
Epicyte Pharmaceutical, Inc. |
Novel epithelial tissue targeting agent
|
|
US6045774A
(en)
|
1997-01-10 |
2000-04-04 |
Epicyte Pharmaceutical Inc. |
J chain polypeptide targeting molecule linked to an imaging agent
|
|
AU3655899A
(en)
|
1998-04-20 |
1999-11-08 |
Regents Of The University Of California, The |
Modified immunoglobulin molecules and methods for use thereof
|
|
DE60042785D1
(de)
|
1999-06-09 |
2009-10-01 |
Immunomedics Inc |
Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
|
|
MXPA02010011A
(es)
*
|
2000-04-11 |
2003-04-25 |
Genentech Inc |
Anticuerpos multivalentes y usos para los mismos.
|
|
DK1290027T3
(da)
|
2000-04-28 |
2010-01-18 |
Planet Biotechnology Inc |
Immunoadhæsin til forebyggelse af rhinovirusinfektion
|
|
US7947463B2
(en)
|
2000-05-10 |
2011-05-24 |
Signe Biopharma, Inc. |
Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
|
|
US7138496B2
(en)
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
US20050129616A1
(en)
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
AU2003208415B2
(en)
|
2002-02-14 |
2009-05-28 |
Immunomedics, Inc. |
Anti-CD20 antibodies and fusion proteins thereof and methods of use
|
|
WO2003074567A2
(en)
|
2002-03-01 |
2003-09-12 |
Immunomedics, Inc. |
Internalizing anti-cd74 antibodies and methods of use
|
|
AU2003234736B2
(en)
|
2002-04-12 |
2008-09-25 |
E. R. Squibb & Sons, L.L.C. |
Methods of treatment using CTLA-4 antibodies
|
|
AU2003277087B2
(en)
|
2002-06-14 |
2008-07-31 |
Immunomedics, Inc. |
Humanized monoclonal antiboby hPAM4
|
|
PT2314629E
(pt)
|
2002-07-18 |
2014-01-22 |
Merus B V |
Produção recombinante de misturas de anticorpos
|
|
EA021644B1
(ru)
*
|
2002-10-17 |
2015-08-31 |
Генмаб А/С |
Человеческое моноклональное антитело против cd20 и его применение
|
|
US20050014932A1
(en)
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
WO2004104046A1
(en)
|
2003-05-23 |
2004-12-02 |
Crucell Holland B.V. |
Production of recombinant igm in per.c6 cells
|
|
ATE490787T1
(de)
|
2003-07-15 |
2010-12-15 |
Chugai Pharmaceutical Co Ltd |
Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion
|
|
US7109304B2
(en)
|
2003-07-31 |
2006-09-19 |
Immunomedics, Inc. |
Humanized anti-CD19 antibodies
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
EP1686137A4
(en)
|
2003-10-09 |
2009-10-28 |
Chugai Pharmaceutical Co Ltd |
PROCESS FOR STABILIZING PROTEIN SOLUTIONS
|
|
HRP20110187T1
(hr)
|
2003-10-16 |
2011-04-30 |
Micromet Ag |
Multispecifične deimunizirane tvari koje vežu cd3
|
|
FR2861255B1
(fr)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
|
EP1697520A2
(en)
|
2003-12-22 |
2006-09-06 |
Xencor, Inc. |
Fc polypeptides with novel fc ligand binding sites
|
|
JP5848861B2
(ja)
|
2004-04-20 |
2016-01-27 |
ジェンマブ エー／エスＧｅｎｍａｂ Ａ／Ｓ |
Ｃｄ２０に対するヒトモノクローナル抗体
|
|
AU2005304973A1
(en)
|
2004-11-05 |
2006-05-18 |
Palingen, Inc. |
Antibody induced cell membrane wounding
|
|
ES2829566T3
(es)
|
2005-03-03 |
2021-06-01 |
Immunomedics Inc |
Anticuerpos L243 humanizados
|
|
US8349332B2
(en)
*
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
|
EP1891113A2
(en)
*
|
2005-06-02 |
2008-02-27 |
AstraZeneca AB |
Antibodies directed to cd20 and uses thereof
|
|
DE602006015653D1
(de)
*
|
2005-08-03 |
2010-09-02 |
Therapeutic Human Polyclonals |
Unterdrückung der b-zell apoptose in transgenen tieren die humanisierte immunglobulingene exprimieren
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
CN103242451B
(zh)
*
|
2005-12-16 |
2017-11-21 |
Ibc医药公司 |
基于免疫球蛋白的多价生物活性装配体
|
|
MX2008008046A
(es)
|
2005-12-21 |
2009-03-04 |
Micromet Ag |
Moleculas de epha2-bite y usos de las mismas.
|
|
NZ596865A
(en)
|
2006-06-12 |
2013-07-26 |
Emergent Product Dev Seattle |
Single-chain multivalent binding proteins with effector function
|
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
|
US20080145420A1
(en)
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
WO2008114011A2
(en)
*
|
2007-03-19 |
2008-09-25 |
Medimmune Limited |
Fc polypeptide variants obtained by ribosome display methodology
|
|
US20100298223A1
(en)
|
2007-05-02 |
2010-11-25 |
Dietmar Rudolf Fries |
Fibrinogen for treatment of bleeding in trauma and platelet disorders
|
|
CN201229536Y
(zh)
|
2008-07-03 |
2009-04-29 |
鸿富锦精密工业（深圳）有限公司 |
电脑机箱
|
|
US20120269830A1
(en)
|
2009-12-07 |
2012-10-25 |
Lawrence Horowitz |
Conjugates with improved pharmacokinetic properties
|
|
AU2010343056A1
(en)
|
2009-12-29 |
2012-08-02 |
Emergent Product Development Seattle, Llc |
Ron binding constructs and methods of use thereof
|
|
US9173961B2
(en)
|
2010-02-10 |
2015-11-03 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
|
MX2012009321A
(es)
|
2010-02-11 |
2012-11-21 |
Alexion Pharma Inc |
Metodos terapeuticos que utilizan anticuerpos anti-cd200.
|
|
AU2011318567B2
(en)
|
2010-10-19 |
2017-02-09 |
Mayo Foundation For Medical Education And Research |
Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
|
|
EP2655415A4
(en)
|
2010-12-22 |
2016-03-09 |
Abbvie Inc |
THREE VARIABLE DOMAIN LINK PROTEINS AND USES THEREOF
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
EP2791171A1
(en)
|
2011-12-16 |
2014-10-22 |
Synthon Biopharmaceuticals B.V. |
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
|
|
ES2735289T3
(es)
|
2012-02-08 |
2019-12-17 |
Igm Biosciences Inc |
Proteínas de unión a cdim y usos de las mismas
|
|
WO2013150138A1
(en)
*
|
2012-04-05 |
2013-10-10 |
Gottfried Himmler |
Secretory immunoglobulin complex
|
|
BR112014025898A2
(pt)
|
2012-04-17 |
2017-11-07 |
Mayo Found Medical Education & Res |
anticorpos humanos e sequências de ligação específica, para uso em acidente vascular cerebral e isquemia ou condições isquêmicas
|
|
US20150175678A1
(en)
|
2012-06-15 |
2015-06-25 |
Beth Israel Deaconess Medical Center, Inc. |
IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
|
|
JP2015524821A
(ja)
*
|
2012-08-02 |
2015-08-27 |
ジェイエヌ バイオサイエンシーズ エルエルシー |
システイン変異及びμ尾部を介して多量体化した抗体又は融合タンパク質
|
|
JOP20200236A1
(ar)
*
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
WO2014124457A1
(en)
|
2013-02-11 |
2014-08-14 |
University Of Louisville Research Foundation, Inc. |
Methods for producing antibodies
|
|
US9487773B2
(en)
|
2013-03-01 |
2016-11-08 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Cell-based methods for coupling protein interactions and binding molecule selection
|
|
GB201311487D0
(en)
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Bispecific molecules
|
|
US20150038682A1
(en)
|
2013-08-02 |
2015-02-05 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via homomultimerizing peptide
|
|
CN105722855B
(zh)
*
|
2013-09-05 |
2021-04-23 |
Igm生物科学股份有限公司 |
恒定链经修饰的双特异性五价和六价Ig-M抗体
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
BR112016015140A2
(pt)
|
2013-12-30 |
2018-01-23 |
Epimab Biotherapeutics Inc. |
imunoglobulina com fabs in-tandem e usos das mesmas
|
|
SG11201605691VA
(en)
|
2014-01-16 |
2016-08-30 |
Mario Umberto Francesco Mondelli |
Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
|
|
KR102378289B1
(ko)
|
2014-02-10 |
2022-03-23 |
아이쥐엠 바이오사이언스 인코포레이티드 |
IgA 다중-특이적 결합 분자
|
|
ES2770684T3
(es)
|
2014-03-14 |
2020-07-02 |
Novartis Ag |
Moléculas de anticuerpos contra LAG-3 y usos de los mismos
|
|
CN112759650B
(zh)
|
2014-04-03 |
2024-10-01 |
Igm生物科学股份有限公司 |
修饰的j链
|
|
CA2972990A1
(en)
|
2015-01-20 |
2016-07-28 |
Beatrice Tien-Yi WANG |
Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof
|
|
WO2016154593A1
(en)
|
2015-03-25 |
2016-09-29 |
Igm Biosciences, Inc. |
Multi-valent hepatitis b virus antigen binding molecules and uses thereof
|
|
CN107847591B
(zh)
|
2015-04-17 |
2023-07-28 |
Igm生物科学股份有限公司 |
多价人免疫缺陷病毒抗原结合分子及其应用
|
|
AU2015242213A1
(en)
|
2015-07-12 |
2018-03-08 |
Hangzhou Dac Biotech Co., Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
WO2017059387A1
(en)
|
2015-09-30 |
2017-04-06 |
Igm Biosciences, Inc. |
Binding molecules with modified j-chain
|
|
PL3355913T3
(pl)
*
|
2015-09-30 |
2025-02-17 |
Igm Biosciences, Inc. |
Cząsteczki wiążące ze zmodyfikowanym łańcuchem j
|
|
DK3455257T3
(da)
|
2016-05-09 |
2021-11-01 |
Igm Biosciences Inc |
Anti-pd-l1-antistoffer
|
|
MX2019000796A
(es)
|
2016-07-20 |
2019-06-03 |
Igm Biosciences Inc |
Moleculas multimericas de union a ox40 y usos de las mismas.
|
|
AU2017300647A1
(en)
|
2016-07-20 |
2019-02-07 |
Igm Biosciences, Inc. |
Multimeric GITR binding molecules and uses thereof
|
|
WO2018017763A1
(en)
|
2016-07-20 |
2018-01-25 |
Igm Biosciences, Inc. |
Multimeric cd40 binding molecules and uses thereof
|
|
EP3487298A4
(en)
|
2016-07-20 |
2020-03-11 |
IGM Biosciences, Inc. |
MULTIMERE CD137 / 4-1BB-BINDING MOLECULES AND USES THEREOF
|
|
KR102696143B1
(ko)
|
2017-04-07 |
2024-08-21 |
아이쥐엠 바이오사이언스 인코포레이티드 |
보체-의존성 세포용해 효과기 기능의 조정을 위한 변형된 인간 IgM 불변 영역
|
|
CN111757941A
(zh)
|
2018-02-26 |
2020-10-09 |
Igm生物科学股份有限公司 |
多聚体抗dr5结合分子与化学治疗剂联合用于治疗癌症的用途
|
|
MX2020009069A
(es)
|
2018-03-01 |
2020-10-08 |
Igm Biosciences Inc |
Mutaciones de fc de igm y de la cadena j que afectan la semivida de igm en suero.
|
|
EP3870223A4
(en)
|
2018-10-23 |
2022-08-24 |
IGM Biosciences, Inc. |
MULTIVALENT IGM AND IGA-FC BASED BINDING MOLECULES
|